The long-term implications of state right-to-repair laws could have devastating consequences for health care providers and their patients.
Top News
Blog Post | June 10, 2021
Press Release | May 25, 2021
WASHINGTON, D.C. – AdvaMed, the world’s largest trade organization representing medical technology manufacturers, released the following statement from President and CEO Scott Whitaker upon Chiquita Brooks-LaSure’s confirmation by the Senate as Administrator of the Centers for Medicare & Medicaid Services (CMS):
Press Release | May 21, 2021
WASHINGTON, D.C. – AdvaMed, the world’s largest trade organization representing medical technology companies, wrote a letter to U.S. Department of Commerce Secretary Gina Raimondo “to strongly encourage the implementation of policies that ensure equal access to semiconductor chips for all industries that rely on them.”
Events
June
16
June 16, 2021 | Online
Join us for our webinar with Sidley Austin on Wednesday, June 16 from 1:00 PM - 2:00 PM ET to better understand the current health care enforcement landscape with the new administration. Don't miss... Read More
September
27
September 27, 2021 to September 30, 2021 | Washington, DC / Minneapolis / Virtual
The MedTech Conference, powered by AdvaMed, will host the conference in a new hybrid structure, combining the benefits of both in-person and virtual events, on September 27th – 30th. Attendees can... Read More
Featured Video
The pandemic struck and the world changed – and medtech adapted. AdvaMed salutes our member companies on the frontlines of the fight against COVID-19.
Industry News
The Frank Baldino CEO of the Year Award recognizes a CEO who has demonstrated visionary leadership and active participation to advance the industry. Frank Baldino, Jr., founder and CEO of Cephalon, Inc., was a pillar of the Life Sciences community in the Greater Philadelphia region and of the biotechnology industry as a whole. Congratulations to award recipient Maureen Mulvihill, Ph.D.!
Like Frank Baldino, Maureen Mulvihill is widely recognized as a visionary leader of Actuated Medical, Inc. (...
MY01 provides the necessary immediate and timely information (1) to aid physicians in monitoring patients at-risk of developing Compartment Syndrome.(2)
MONTREAL, May 6, 2021 /PRNewswire/ - MY01 Inc. is on a mission to empower healthcare professionals with the ability to pre-empt severe medical conditions, improving patient outcomes. MY01 inc. today announced U.S. Food and Drug Administration 510(k) clearance for the MY01 Continuous Compartment Pressure Monitor with full Bluetooth...
San Diego— March 8, 2021 — iAssay, Inc., and DDTD (Drugs & Diagnostics for Tropical Diseases), a 501(c)(3) nonprofit, have signed a Memorandum of Understanding (MOU). DDTD is a mission-driven organization to develop accurate, affordable, mass-market treatments and diagnostics for low-resourced and under-served organizations. This step enables organizations to provide DDTD’s high performance COVID-19 serology tests along with automatic digitized reads that are transmitted simultaneously and...
SALT LAKE CITY--(BUSINESS WIRE)--O2TODAY ("O2TODAY"), a mask company that develops, manufactures and commercializes face masks for medical and non-medical uses, and SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”) (www.sintx.com), an original equipment manufacturer (OEM) of silicon nitride ceramics, announced today they have entered into a worldwide exclusive licensing agreement.
O2TODAY expects to release their first consumer mask integrated with SINTX’s silicon nitride...
BOSTON, Jan. 20, 2021 -- Haemonetics Corporation (NYSE: HAE) ("Haemonetics"), a global medical technology company focused on delivering innovative medical solutions to drive better patient outcomes, today announced that it has entered into a definitive agreement to acquire privately-held Cardiva Medical, Inc., ("Cardiva") an industry-leading manufacturer of vascular closure systems based in Santa Clara, California. Under the terms of the agreement, Haemonetics will acquire Cardiva for an...
Twitter Feed
June 11, 2021 - 12:36pm
AdvaMed’s Chief Policy Officer, @ChrisMedtech, explains how non-FDA regulated third-party repairs can put patients,… https://t.co/UH6wAie8vO
June 11, 2021 - 11:10am
RT @jimmyjeffries: The #MCIT rule currently under review by CMS & supported by @AdvaMedUpdate would give breakthrough devices deemed s… https://t.co/4XMiRUnulf